Publication | Open Access
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
533
Citations
24
References
2019
Year
ClinicalTrials.gov identifier: NCT02657889.
| Year | Citations | |
|---|---|---|
Page 1
Page 1